BioGeneration Ventures

VC fundNaarden, Netherlandsbiogenerationventures.com

BioGeneration Ventures focuses on seed-stage investments in European life sciences companies with high unmet medical needs.

What they invest in

Stages

Seed Series A

Sectors

Biotech & Pharma

Geographies

The facts

Typical cheque: €1M – €10M
Headquarters: Naarden, Netherlands
Founded: 2006

Selected portfolio

AzafarosVectorY TherapeuticsTargED BiopharmaceuticalsCitryllBrenig TherapeuticsAvidicureScenic BiotechVarmXCatalymEscalier BiosciencesKivu BiosciencesFundaMental PharmaCristal TherapeuticsConfo TherapeuticsEpsilogenMellon MedicalLink ImmunotherapeuticsDualyxDunad TherapeuticsMironidRhygazePadarn TherapeuticsTegid TherapeuticsRiver BioMedics

and 14 more

Recent rounds

Azafaros
€132MSeries BHealthTech
Forbion GrowthleadJeitoleadBioGeneration VenturesSchrodersForbion · +2 more in the source
14 May 2025Netherlandssiliconcanals.com
Citryll
€85MSeries BHealthTech
Forbionlead Novartis Venture FundleadBioGeneration VenturesDe Brabantse Ontwikkelings Maatschappij Pureos Bioventures Seventure Partners · +3 more in the source
10 December 2024Netherlandssiliconcanals.com

Rounds BioGeneration Ventures took part in, as reported by the linked articles. See who else is investing right now.

Does BioGeneration Ventures fit your round?

In 30 minutes you'll know which funds matter for your round.

Book a call

Are you BioGeneration Ventures? Tell us what to correct and we will update it — or ask us to remove the entry.